ACUIX
Price
$39.19
Change
-$0.02 (-0.05%)
Updated
Aug 28 closing price
Net Assets
2.17B
VIVAX
Price
$71.45
Change
+$0.01 (+0.01%)
Updated
Aug 28 closing price
Net Assets
195.81B
Interact to see
Advertisement

ACUIX vs VIVAX

Header iconACUIX vs VIVAX Comparison
Open Charts ACUIX vs VIVAXBanner chart's image
Columbia Dividend Opportunity C
Price$39.19
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets2.17B
Vanguard Value Index I
Price$71.45
Change+$0.01 (+0.01%)
VolumeN/A
Net Assets195.81B
ACUIX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ACUIX vs. VIVAX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUIX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 196B vs. ACUIX (2.17B). VIVAX pays higher dividends than ACUIX: VIVAX (2.06) vs ACUIX (1.95). ACUIX was incepted earlier than VIVAX: ACUIX (25 years) vs VIVAX (33 years). ACUIX (1.82) is less costly to investors than VIVAX (0.17). ACUIX is a more actively managed with annual turnover of: 36.00 vs. VIVAX (9.00). ACUIX has a lower initial minimum investment than VIVAX: ACUIX (2000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 7.44 vs. ACUIX (4.98). VIVAX return over 5 years is better than : 69.16 vs. ACUIX (36.98).
ACUIXVIVAXACUIX / VIVAX
Total Expense Ratio1.820.171,071%
Annual Report Gross Expense Ratio1.820.171,071%
Fund Existence25 years33 years-
Gain YTD9.6788.193118%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B196B1%
Annual Yield % from dividends1.952.0695%
Returns for 1 year4.987.4467%
Returns for 3 years18.9833.5257%
Returns for 5 years36.9869.1653%
Returns for 10 years36.12131.5627%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDTZX25.56N/A
N/A
Fidelity Advisor Capital Development M
QASCX28.21N/A
N/A
Federated Hermes MDT Small Cap Core A
MGFRX9.61N/A
N/A
MassMutual Global R4
RSIRX14.43N/A
N/A
Victory RS International R6
ELMFX18.75N/A
N/A
Lord Abbett Emerging Markets Equity F